SCHEMBL4109568

SCHEMBL4109568

COC(=O)CC(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
KMO O15229 3/20 0.50
TSHR P16473 1/20 0.50
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC9 Q9UKV0 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31266408 1.00 HPGD (0.55) HPGDMEN1KMT2AKMOTSHR
SCHEMBL3668982 0.86 HPGD (0.53) HPGDKMOTSHRHDAC3HDAC4
SCHEMBL31299787 0.85 KDM4E (0.51) HPGDMEN1KMT2AKMOTSHR
SCHEMBL1348885 0.85 KDM4E (0.51) HPGDMEN1KMT2AKMOTSHR
SCHEMBL23294373 0.85 MEN1 (0.50) HPGDMEN1KMT2ATSHRRAB9A
SCHEMBL9015106 0.85 TSHR (0.61) HPGDMEN1KMT2AKMOTSHR
SCHEMBL6810549 0.83 L3MBTL1 (0.57) HPGDKMOTSHRHDAC3HDAC4
SCHEMBL6990537 0.83 HPGD (0.53) HPGDMEN1KMT2ATSHRRAB9A
SCHEMBL25268811 0.83 HPGD (0.53) HPGDKMOTSHRHDAC3HDAC4
SCHEMBL30481570 0.83 HPGD (0.53) HPGDKMOTSHRHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107698511-B 1, 3-diaryl-5-alkoxy pyrazole compound and preparation method and application thereof 福州大学 2020-05-08 CN claimed
CN-107162978-B A kind of tri- substituted pyrazole compounds of 1,3,5- and its preparation method and application 福州大学 2019-06-07 CN claimed
CN-107162978-A A kind of 1,3,5 3 substituted pyrazole compounds and its preparation method and application 福州大学 2017-09-15 CN claimed
CN-116568135-B Herbicidal derivatives Syngenta Crop Protection JSC (CH) 2026-05-26 CN disclosed
EP-4581016-A1 HERBICIDAL PYRIDONE DERIVATIVES Syngenta Crop Protection AG (CH) 2025-07-09 EP disclosed
EP-4532482-A1 HERBICIDAL DERIVATIVES Syngenta Crop Protection AG (CH) 2025-04-09 EP disclosed
CN-119731155-A Herbicidal pyridone derivatives 先正达农作物保护股份公司 2025-03-28 CN disclosed
CN-119421873-A Herbicidal derivatives 先正达农作物保护股份公司 2025-02-11 CN disclosed
CN-119301109-A Herbicidal derivatives 先正达农作物保护股份公司 2025-01-10 CN disclosed
EP-4479382-A1 HERBICIDAL QUINOLONE DERIVATIVES Syngenta Crop Protection AG (CH) 2024-12-25 EP disclosed
CN-118679148-A Herbicidal quinolone derivatives 先正达农作物保护股份公司 2024-09-20 CN disclosed
CN-107162978-A A kind of 1,3,5 3 substituted pyrazole compounds and its preparation method and application 福州大学 2017-09-15 CN disclosed
WO-2012149157-A2 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2012-11-01 WO disclosed
WO-2012149157-A2 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2012-11-01 WO disclosed
US-20120277224-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2012-11-01 US disclosed
US-20120277224-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2012-11-01 US disclosed
US-20120277224-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2012-11-01 US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed
EP-1851232-A2 DIHYDROIMIDAZOTHIAZOLE DERIVATIVES Prosidion Limited (GB) 2007-11-07 EP disclosed
WO-2006085118-A2 DIHYDROIMIDAZOTHIAZOLE DERIVATIVES PROSIDION LIMITED (GB) 2006-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277224-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK PASK, PDXK, PANK2 HPGD 824/4885MEN1 3040/4885KMT2A 3661/4885
US-20090221645-A1 Dihydroimidazothiazole Derivatives TPH1, HTR3B, HTR1A HPGD 935/4885MEN1 2481/4885KMT2A 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.